title: Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection.
abstract: Piperacillin/tazobactam (PTZ) is frequently used in patients with diabetic foot infections. Herein, we report a patient who developed severe neutropenia, thrombocytopenia, and fever while receiving PTZ for a diabetic foot infection. We recommend vigilance when long-term PTZ use is planned in patients with diabetic foot infections.
authors: GATA Haydarpaşa Eğitim Hastanesi, Sualtıve Hiperbarik Tıp Servisi, 34668 Üsküdar, Istanbul, Turkey. gunalpuzun@gmail.com
authors: Günalp
authors: G
authors: Uzun
authors: Yalçin
authors: Y
authors: Onem
authors: Mustafa
authors: M
authors: Hatipoglu
authors: Vedat
authors: V
authors: Turhan
authors: Mesut
authors: M
authors: Mutluoglu
authors: Hakan
authors: H
authors: Ay
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy; D017719:Diabetic Foot / Q000097:blood* / Q000188:drug therapy / Q000601:surgery; D005334:Fever / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000139:chemically induced*; D010397:Penicillanic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000009:adverse effects / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D000900:Anti-Bacterial Agents; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D010878:Piperacillin